Genome Medicine

Scope & Guideline

Catalyzing Discoveries in Molecular Medicine

Introduction

Welcome to the Genome Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Genome Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1756-994x
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2009 to 2024
AbbreviationGENOME MED / Genome Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Genome Medicine is dedicated to advancing the integration of genomic and molecular data into clinical practice and public health. The journal emphasizes innovative research that bridges the gap between laboratory findings and their application in medicine, particularly focusing on the implications of genomic research in understanding disease mechanisms, diagnostics, and therapeutic strategies.
  1. Genomic Medicine and Diagnostics:
    The journal highlights research that explores the role of genomic information in diagnosing various diseases, including rare genetic disorders and cancers, emphasizing the clinical utility of whole genome sequencing and targeted genetic testing.
  2. Precision Medicine and Therapeutics:
    A core focus is on the development of precision medicine approaches, including the identification of genetic variants that influence treatment responses and the exploration of personalized therapeutic strategies based on genomic data.
  3. Public Health Genomics:
    Research addressing the implications of genomics in public health, including the genetic epidemiology of diseases and the role of genomics in infectious disease surveillance and control.
  4. Multi-Omics Integration:
    The journal promotes studies that utilize multi-omics approaches (genomics, transcriptomics, proteomics, metabolomics) to provide a comprehensive understanding of disease mechanisms and treatment responses.
  5. Ethics and Policy in Genomics:
    Genome Medicine also considers the ethical implications and policy issues surrounding genetic research and its application in clinical settings, including data sharing and patient consent.
Recent publications in Genome Medicine reflect evolving trends and emerging themes that are shaping the future of genomic research and its application in medicine. These trends highlight the journal's responsiveness to current scientific needs and societal challenges.
  1. Integration of AI and Machine Learning:
    There is a rising trend in the application of artificial intelligence and machine learning techniques to enhance genomic analysis, improve diagnostic accuracy, and predict treatment responses, showcasing the intersection of technology and genomics.
  2. Focus on Health Disparities and Ancestry:
    Recent studies increasingly address genetic diversity and health disparities among different populations, emphasizing the importance of considering ancestry in genomic research and clinical applications.
  3. Microbiome Research in Disease Contexts:
    The exploration of the human microbiome's role in health and disease is gaining traction, with studies linking microbiome profiles to various conditions, including cancer and metabolic disorders.
  4. Liquid Biopsy and Non-Invasive Testing:
    Emerging research focuses on non-invasive techniques, such as liquid biopsies, for cancer detection and monitoring, reflecting a shift towards more patient-friendly diagnostic methods.
  5. Spatial and Single-Cell Omics:
    Advancements in spatial transcriptomics and single-cell genomics are becoming prominent, enabling researchers to explore cellular heterogeneity and the tumor microenvironment in unprecedented detail.

Declining or Waning

While Genome Medicine continues to evolve and adapt to emerging research areas, certain themes have seen a decline in prominence over recent years. These waning scopes reflect shifts in research focus and funding priorities in the field of genomics and medicine.
  1. Traditional Genetic Association Studies:
    The journal has seen a decrease in papers focused solely on traditional genetic association studies without integrating genomic data with other omics or clinical features. This shift indicates a move towards more comprehensive approaches that incorporate multiple layers of biological data.
  2. Single-Method Approaches:
    There is a noticeable decline in the publication of studies relying on single-method approaches, such as single-nucleotide polymorphism (SNP) analyses, as researchers increasingly favor integrative techniques that combine various methodologies for richer insights.
  3. Basic Science Without Clinical Relevance:
    Research that lacks direct implications for clinical practice or public health has become less common, suggesting a growing expectation for studies to demonstrate translational potential.

Similar Journals

Annual Review of Genomics and Human Genetics

Synthesis of Knowledge: The Pinnacle of Genomic Research
Publisher: ANNUAL REVIEWSISSN: 1527-8204Frequency: 1 issue/year

Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

Molecular & Cellular Oncology

Connecting researchers to the forefront of oncology.
Publisher: TAYLOR & FRANCIS INCISSN: Frequency: 6 issues/year

Molecular & Cellular Oncology, published by Taylor & Francis Inc, is a vital academic journal dedicated to the exploration of cancer biology through the lens of molecular and cellular mechanisms. Since its inception in 2014, the journal has played a crucial role in disseminating innovative research findings that address the fundamental aspects of cancer research and molecular medicine. With its current ranking in Scopus placing it in the Q3 quartile for both Cancer Research and Molecular Medicine, the journal provides a platform for groundbreaking studies that push the boundaries of our understanding of oncogenesis and therapeutic interventions. Although the journal operates under a subscription model, its dedication to high-quality peer-reviewed research makes it an essential resource for researchers, professionals, and students aiming to contribute to or stay updated in the rapidly evolving field of oncology. As we approach the culmination of its converged years in 2024, Molecular & Cellular Oncology aims to continue fostering collaborations and insights that advance cancer research on a global scale.

EUROPEAN JOURNAL OF HUMAN GENETICS

Connecting Researchers in the Field of Human Genetics
Publisher: SPRINGERNATUREISSN: 1018-4813Frequency: 12 issues/year

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.

npj Genomic Medicine

Bridging Science and Healthcare through Genomics
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.

Cold Spring Harbor Perspectives in Medicine

Illuminating the Path of Medical Discovery
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2157-1422Frequency: 12 issues/year

Cold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.

Genes

Connecting researchers to shape the future of genetics.
Publisher: MDPIISSN: Frequency: 12 issues/year

Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Connecting Research and Discovery in Human Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Asian Biomedicine

Exploring the Frontiers of Biomedical Science
Publisher: WALTER DE GRUYTER GMBHISSN: 1905-7415Frequency: 6 issues/year

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

JCO Precision Oncology

Elevating Treatment Strategies Through Genetic Insights
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 1 issue/year

JCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.

Journal of Molecular Cell Biology

Empowering researchers with open access knowledge.
Publisher: OXFORD UNIV PRESSISSN: 1674-2788Frequency: 6 issues/year

The Journal of Molecular Cell Biology, published by Oxford University Press, is a leading platform for groundbreaking research in the fields of cell biology, genetics, and molecular biology. With an impact factor that places it in the Q1 and Q2 quartiles across key academic categories, this journal has become an essential resource for researchers and professionals committed to advancing our understanding of cellular mechanisms and genetic processes. Since becoming Open Access in 2019, it has enhanced the accessibility of high-quality research, fostering collaboration and knowledge sharing within the scientific community. The journal's Scopus rankings reflect its significant impact in the field, particularly in genetics and molecular biology, ranking within the top percentiles. With a convergence of research spanning from 2009 to 2024, the Journal of Molecular Cell Biology remains at the forefront of innovative discoveries and critical discussions, making it a vital resource for students, academics, and industry experts alike.